For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Exagen Inc (NASDAQ: XGN) closed the day trading at $7.06 up 1.29% from the previous closing price of $6.97. In other words, the price has increased by $1.29% from its previous closing price. On the day, 0.57 million shares were traded. XGN stock price reached its highest trading level at $7.35 during the session, while it also had its lowest trading level at $6.83.
Ratios:
For a better understanding of XGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 3.66 whereas as Long-Term Debt/Eq ratio is at 3.09.
On April 15, 2021, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $25.Canaccord Genuity initiated its Buy rating on April 15, 2021, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 25 ’25 when NMSIC Co-Investment Fund, L.P. sold 350,000 shares for $3.30 per share. The transaction valued at 1,155,000 led to the insider holds 1,758,958 shares of the business.
NMSIC Co-Investment Fund, L.P. sold 200,000 shares of XGN for $660,040 on Nov 20 ’24. The 10% Owner now owns 2,108,958 shares after completing the transaction at $3.30 per share. On Nov 15 ’24, another insider, Black Jeffrey G., who serves as the Chief Financial Officer of the company, bought 22,298 shares for $2.98 each. As a result, the insider paid 66,448 and bolstered with 274,492 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XGN now has a Market Capitalization of 154295600 and an Enterprise Value of 139461056. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.72 while its Price-to-Book (P/B) ratio in mrq is 19.79. Its current Enterprise Value per Revenue stands at 2.459 whereas that against EBITDA is -11.346.
Stock Price History:
The Beta on a monthly basis for XGN is 1.60, which has changed by 2.795699 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, XGN has reached a high of $7.95, while it has fallen to a 52-week low of $1.71. The 50-Day Moving Average of the stock is 11.82%, while the 200-Day Moving Average is calculated to be 64.08%.
Shares Statistics:
Over the past 3-months, XGN traded about 234.80K shares per day on average, while over the past 10 days, XGN traded about 304740 shares per day. A total of 17.95M shares are outstanding, with a floating share count of 11.20M. Insiders hold about 48.77% of the company’s shares, while institutions hold 28.53% stake in the company. Shares short for XGN as of 1748563200 were 177772 with a Short Ratio of 0.76, compared to 1745971200 on 90485. Therefore, it implies a Short% of Shares Outstanding of 177772 and a Short% of Float of 1.0.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
